Literature DB >> 28561705

Metabolic Alterations in Cancer and Their Potential as Therapeutic Targets.

Jamie D Weyandt1, Craig B Thompson1, Amato J Giaccia1, W Kimryn Rathmell1.   

Abstract

Otto Warburg's discovery in the 1920s that tumor cells took up more glucose and produced more lactate than normal cells provided the first clues that cancer cells reprogrammed their metabolism. For many years, however, it was unclear as to whether these metabolic alterations were a consequence of tumor growth or an adaptation that provided a survival advantage to these cells. In more recent years, interest in the metabolic differences in cancer cells has surged, as tumor proliferation and survival have been shown to be dependent upon these metabolic changes. In this educational review, we discuss some of the mechanisms that tumor cells use for reprogramming their metabolism to provide the energy and nutrients that they need for quick or sustained proliferation and discuss the potential for therapeutic targeting of these pathways to improve patient outcomes.

Entities:  

Mesh:

Year:  2017        PMID: 28561705      PMCID: PMC5954416          DOI: 10.1200/EDBK_175561

Source DB:  PubMed          Journal:  Am Soc Clin Oncol Educ Book        ISSN: 1548-8748


  47 in total

1.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

2.  The somatic genomic landscape of chromophobe renal cell carcinoma.

Authors:  Caleb F Davis; Christopher J Ricketts; Min Wang; Lixing Yang; Andrew D Cherniack; Hui Shen; Christian Buhay; Hyojin Kang; Sang Cheol Kim; Catherine C Fahey; Kathryn E Hacker; Gyan Bhanot; Dmitry A Gordenin; Andy Chu; Preethi H Gunaratne; Michael Biehl; Sahil Seth; Benny A Kaipparettu; Christopher A Bristow; Lawrence A Donehower; Eric M Wallen; Angela B Smith; Satish K Tickoo; Pheroze Tamboli; Victor Reuter; Laura S Schmidt; James J Hsieh; Toni K Choueiri; A Ari Hakimi; Lynda Chin; Matthew Meyerson; Raju Kucherlapati; Woong-Yang Park; A Gordon Robertson; Peter W Laird; Elizabeth P Henske; David J Kwiatkowski; Peter J Park; Margaret Morgan; Brian Shuch; Donna Muzny; David A Wheeler; W Marston Linehan; Richard A Gibbs; W Kimryn Rathmell; Chad J Creighton
Journal:  Cancer Cell       Date:  2014-08-21       Impact factor: 31.743

3.  Targeting GLUT1 and the Warburg effect in renal cell carcinoma by chemical synthetic lethality.

Authors:  Denise A Chan; Patrick D Sutphin; Phuong Nguyen; Sandra Turcotte; Edwin W Lai; Alice Banh; Gloria E Reynolds; Jen-Tsan Chi; Jason Wu; David E Solow-Cordero; Muriel Bonnet; Jack U Flanagan; Donna M Bouley; Edward E Graves; William A Denny; Michael P Hay; Amato J Giaccia
Journal:  Sci Transl Med       Date:  2011-08-03       Impact factor: 17.956

Review 4.  mTOR signaling at a glance.

Authors:  Mathieu Laplante; David M Sabatini
Journal:  J Cell Sci       Date:  2009-10-15       Impact factor: 5.285

Review 5.  The metabolic basis of kidney cancer.

Authors:  W Marston Linehan; Christopher J Ricketts
Journal:  Semin Cancer Biol       Date:  2012-06-13       Impact factor: 15.707

Review 6.  State of the science: an update on renal cell carcinoma.

Authors:  Eric Jonasch; P Andrew Futreal; Ian J Davis; Sean T Bailey; William Y Kim; James Brugarolas; Amato J Giaccia; Ghada Kurban; Armin Pause; Judith Frydman; Amado J Zurita; Brian I Rini; Pam Sharma; Michael B Atkins; Cheryl L Walker; W Kimryn Rathmell
Journal:  Mol Cancer Res       Date:  2012-05-25       Impact factor: 5.852

Review 7.  Links between metabolism and cancer.

Authors:  Chi V Dang
Journal:  Genes Dev       Date:  2012-05-01       Impact factor: 11.361

8.  Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer.

Authors:  Matt I Gross; Susan D Demo; Jennifer B Dennison; Lijing Chen; Tania Chernov-Rogan; Bindu Goyal; Julie R Janes; Guy J Laidig; Evan R Lewis; Jim Li; Andrew L Mackinnon; Francesco Parlati; Mirna L M Rodriguez; Peter J Shwonek; Eric B Sjogren; Timothy F Stanton; Taotao Wang; Jinfu Yang; Frances Zhao; Mark K Bennett
Journal:  Mol Cancer Ther       Date:  2014-02-12       Impact factor: 6.261

9.  Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis.

Authors:  Yan Xiang; Zachary E Stine; Jinsong Xia; Yunqi Lu; Roddy S O'Connor; Brian J Altman; Annie L Hsieh; Arvin M Gouw; Ajit G Thomas; Ping Gao; Linchong Sun; Libing Song; Benedict Yan; Barbara S Slusher; Jingli Zhuo; London L Ooi; Caroline G L Lee; Anthony Mancuso; Andrew S McCallion; Anne Le; Michael C Milone; Stephen Rayport; Dean W Felsher; Chi V Dang
Journal:  J Clin Invest       Date:  2015-04-27       Impact factor: 14.808

10.  Phenformin Induces Cell Cycle Change, Apoptosis, and Mesenchymal-Epithelial Transition and Regulates the AMPK/mTOR/p70s6k and MAPK/ERK Pathways in Breast Cancer Cells.

Authors:  Zhao Liu; Lidong Ren; Chenghao Liu; Tiansong Xia; Xiaoming Zha; Shui Wang
Journal:  PLoS One       Date:  2015-06-26       Impact factor: 3.240

View more
  16 in total

1.  A lysosomal proton pump turns on when glucose runs out.

Authors:  Karlett J Parra; Summer R Hayek
Journal:  J Biol Chem       Date:  2018-06-08       Impact factor: 5.157

Review 2.  Dysregulation of metabolic enzymes in tumor and stromal cells: Role in oncogenesis and therapeutic opportunities.

Authors:  Mohammad Aslam Khan; Haseeb Zubair; Shashi Anand; Sanjeev Kumar Srivastava; Seema Singh; Ajay Pratap Singh
Journal:  Cancer Lett       Date:  2020-01-07       Impact factor: 8.679

Review 3.  MicroRNAs and Corresponding Targets in Esophageal Cancer as Shown In Vitro and In Vivo in Preclinical Models.

Authors:  Ulrich H Weidle; Adam Nopora
Journal:  Cancer Genomics Proteomics       Date:  2022 Mar-Apr       Impact factor: 4.069

Review 4.  The burning furnace: Alteration in lipid metabolism in cancer-associated cachexia.

Authors:  Mit Joshi; Bhoomika M Patel
Journal:  Mol Cell Biochem       Date:  2022-03-07       Impact factor: 3.396

5.  Metabolic Interactions Between Tumor and Stromal Cells in the Tumor Microenvironment.

Authors:  Deepshikha Mishra; Debabrata Banerjee
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 6.  The emerging role of selenium metabolic pathways in cancer: New therapeutic targets for cancer.

Authors:  Kalishwaralal Kalimuthu; Chenicheri K Keerthana; Manikandan Mohan; Jaison Arivalagan; Johnson Retnaraj Samuel Selvan Christyraj; Michael A Firer; Mohammad Haroon Asif Choudry; Ruby John Anto; Yong J Lee
Journal:  J Cell Biochem       Date:  2021-12-21       Impact factor: 4.429

7.  SIRT4 functions as a tumor suppressor during prostate cancer by inducing apoptosis and inhibiting glutamine metabolism.

Authors:  Zhuhui Ge; Yunqiu Xu; Guohao Cai; Liangliang Cai; Pingliang Sun; Guoyu Huang
Journal:  Sci Rep       Date:  2022-07-16       Impact factor: 4.996

8.  mTORC1 stimulates cell growth through SAM synthesis and m6A mRNA-dependent control of protein synthesis.

Authors:  Elodie Villa; Umakant Sahu; Brendan P O'Hara; Eunus S Ali; Kathryn A Helmin; John M Asara; Peng Gao; Benjamin D Singer; Issam Ben-Sahra
Journal:  Mol Cell       Date:  2021-03-22       Impact factor: 17.970

Review 9.  Microbes in Tumoral In Situ Tissues and in Tumorigenesis.

Authors:  Xue Feng; Lu Han; Sijia Ma; Lanbo Zhao; Lei Wang; Kailu Zhang; Panyue Yin; Lin Guo; Wei Jing; Qiling Li
Journal:  Front Cell Infect Microbiol       Date:  2020-11-24       Impact factor: 5.293

Review 10.  X-change symposium: status and future of modern radiation oncology-from technology to biology.

Authors:  Stefanie Corradini; Maximilian Niyazi; Dirk Verellen; Vincenzo Valentini; Seán Walsh; Anca-L Grosu; Kirsten Lauber; Amato Giaccia; Kristian Unger; Jürgen Debus; Bradley R Pieters; Matthias Guckenberger; Suresh Senan; Wilfried Budach; Roland Rad; Julia Mayerle; Claus Belka
Journal:  Radiat Oncol       Date:  2021-02-04       Impact factor: 4.309

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.